Tradestie Institutional Equity Comparison Engine

SRPT vs BHVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BHVN Overall Edge

BHVN Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biohaven Ltd. (BHVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SRPT counters with relative strength in Valuation. Fundamentally, SRPT trades at 10.8x Forward P/E with -0.4% operating margin (-4.5% YoY revenue) versus BHVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SRPT sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SRPT
SRPT 10.8x vs BHVN N/M Fwd P/E
Growth & Margin Winner BHVN
Op Margin -0.4% vs 0.0% ยท YoY -4.5% vs +0.0%
Momentum & Technical Winner BHVN
1Y -14.4% vs +72.6% ยท 52W Pos 6% vs 59%
Options & Structure Winner BHVN
BREAKDOWN (7th %ile IV) vs CONSOLIDATION (18th %ile IV)
SRPT NASDAQ
Sarepta Therapeutics,, Inc. Common Stock
Pharmaceutical Preparations
$15.25
-5.1% 1D
Market Cap $1.7B
1M Return -10.82%
1Y Return -14.42%
Forward P/E 10.8x
Unified AI Score
37.8 / 100 SELL
Tech 32.0 Fund 51.0 Flow 71.0 Mom 60.0
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.95
+0.9% 1D
Market Cap $2.1B
1M Return +29.36%
1Y Return +72.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SRPT -14.42% BHVN +72.59% Spread: +87.01 pp (BHVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SRPT TTM Op. Margin: -0.4% BHVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRPT vs BHVN. Trailing 12-month operating profitability (SRPT -0.4% vs BHVN 0.0%) and valuation multiples (SRPT 10.8x vs BHVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SRPT (3) vs BHVN (6)
Institutional Metric SRPT BHVN Criterion Row Winner
Market Capitalization Scale $1.7B $2.1B Larger Scale BHVN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation 10.8x N/M Lower Multiple SRPT
Revenue Growth (YoY) Growth -4.5% +0.0% Higher Growth BHVN
Operating Margin (TTM) Profitability -0.4% 0.0% Higher Margin BHVN
Net Profit Margin Profitability -5.9% 0.0% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -8.1% -799.5% Higher ROE SRPT
52-Week Range Position Momentum 6% ($15โ€“$25) 59% ($8โ€“$18) Stronger Trend BHVN
Beta / 30D Volatility Risk Regime 1.48ฮฒ ยท 59% Vol 1.40ฮฒ ยท 111% Vol Lower Realized Risk SRPT
Unified Institutional Score Composite Signal 37.8 / 100 (SELL) 42.1 / 100 (HOLD) Higher Composite BHVN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SRPT vs BHVN Buy Guide
SRPT BREAKDOWN
52d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live SRPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SRPT nor BHVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.